Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Pharmaceuticals

March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...

Home March 31, 2022
Home
News | Pharmaceuticals

March 22, 2022 – Fresenius Kabi, a global health care company that specializes in medicines and technologies for ...

Home March 22, 2022
Home
News | Heart Failure

March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of ...

Home March 04, 2022
Home
News | Heart Failure

February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of ...

Home February 24, 2022
Home
News | Pharmaceuticals

January 5, 2022 — The Feinstein Institutes for Medical Research, the science arm of Northwell Health, recently received ...

Home January 05, 2022
Home
News | Coronavirus (COVID-19)

January 4, 2022 — The Omicron variant, as of Dec. 25, made up 58.6% of new COVID-19 infections in the U.S., according to ...

Home January 04, 2022
Home
News | Pharmaceuticals

January 4, 2022 —  The U.S. Food and Drug Administration (FDA) has cleared Novartis' inclisiran (Leqvio), the first ...

Home January 04, 2022
Home
News | Coronavirus (COVID-19)

January 3, 2022 — The U.S. Food and Drug Administration (FDA) recently revised its Janssen COVID-19 Vaccine Fact Sheets ...

Home January 03, 2022
Home
News | Pharmaceuticals

December 16, 2021 – Spanish pharmaceutical company Ferrer and the Spanish National Center for Cardiovascular Research ...

Home December 16, 2021
Home
Here is a list of all the AHA 2021 late-breaking clinical trials and studies. #AHA #AHA21 #AHA2021
Feature | AHA | By Dave Fornell, DAIC Editor

The following are the late-breaking science presentation sessions at the 2021 American Heart Association (AHA) 2021 ...

Home November 23, 2021
Home
News | Coronavirus (COVID-19)

November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...

Home November 23, 2021
Home
News | Venous Therapies

November 22, 2021 — Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral ...

Home November 22, 2021
Home
Videos | Pharmaceuticals

Susan Cheng, M.D., MPH, director of the Institute for Research on Healthy Aging in the Department of Cardiology at ...

Home November 22, 2021
Home
News | Heart Failure

November 19, 2021 — Adults treated with empagliflozin during hospitalization for acute heart failure experienced a ...

Home November 19, 2021
Home
News | Coronavirus (COVID-19)

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

Home November 19, 2021
Home
Subscribe Now